Wei Wang
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 84
- Cancer Research top 0.5%
- MicroRNA in disease regulation 35
-
- Radiomics and Machine Learning in Medical Imaging 69
- Health Informatics top 1%
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 46
-
- Liver Disease Diagnosis and Treatment 86
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 60
-
- Gastric Cancer Management and Outcomes 48
-
- Ultrasound and Hyperthermia Applications 34
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Wang
612 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Hepatology 2.1k
- Cancer Research 1.7k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Health Informatics 136
- Oncology 1.9k
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 62 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 10 | |
| 13 | 2023 | 9 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 63 | |
| 17 | 2021 | 46 | |
| 18 | 2018 | 12 | |
| 19 | 2018 | 36 | |
| 20 | 2013 | 161 |
About Wei Wang
Wei Wang is a scholar working on Hepatology, Gastroenterology and Radiology, Nuclear Medicine and Imaging, having authored 657 papers that have together received 12.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (86 papers), Hepatocellular Carcinoma Treatment and Prognosis (84 papers), Radiomics and Machine Learning in Medical Imaging (69 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (60 papers), Gastric Cancer Management and Outcomes (48 papers), Pancreatic and Hepatic Oncology Research (46 papers), MicroRNA in disease regulation (35 papers) and Ultrasound and Hyperthermia Applications (34 papers). The work is most often cited by research in Hepatology (2.1k citations), Cancer Research (1.7k citations) and Radiology, Nuclear Medicine and Imaging (2.5k citations). Wei Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaoyan Xie, Ming‐De Lu, Ming Kuang, Li‐Da Chen, Ming Xu, Yang Huang, Shi‐Ting Feng, Duojia Pan, Jinyu Liang and Shuling Chen. Their work appears in journals such as European Radiology, Frontiers in Oncology, Medicine, Scientific Reports and Journal of Ultrasound in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.